In what could be one of its last reports as a public company, Portland-based Covetrus Inc. (Nasdaq: CVET) said Thursday its second-quarter net sales rose 2% from the total during the same period last year.
The animal-health company also shrank its quarterly loss to $4 million, of 3 cents per share, for the three-month period that ended June 30, 2022. That’s down from a loss of $31 million, or 23 cents per share, during last year’s second quarter. Read more
ORONO — University of Maine ecology professor Brian McGill was awarded the Humboldt Research Award, one of the most prestigious scientific...
Four workforce training programs in Maine could receive nearly $6.5 million in federal funding through the markup of the fiscal year 2024 financial...
Doctors may soon start writing an unconventional prescription to help stroke survivors regain their ability to walk: music. MedRhythms, a Portland...